New paradigms on antibiotic recommendations for community-acquired infections in Spain
Copyright © 2023 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved..
Over the last years, the susceptibility activity of the most common microorganisms causing community-acquired infections has significantly changed in Spain. Based on the susceptibility rates of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae collected from outpatients aged 15 or older with symptoms of respiratory or urinary tract infections in several Microbiology Departments in Catalonia in 2021, penicillin V should be first choice for most respiratory tract infections, amoxicillin and clavulanate for chronic obstructive pulmonary disease exacerbations and a single dose of fosfomycin or a short-course nitrofurantoin should remain first-line treatments for uncomplicated urinary tract infections. Updated information on antimicrobial resistance for general practitioners is crucial for achieving appropriate empirical management of the most common infections by promoting more rational antibiotic use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Atencion primaria - 55(2023), 8 vom: 15. Aug., Seite 102648 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Llor, Carl [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 01.08.2023 Date Revised 01.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.aprim.2023.102648 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356706400 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356706400 | ||
| 003 | DE-627 | ||
| 005 | 20231226071028.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.aprim.2023.102648 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356706400 | ||
| 035 | |a (NLM)37167756 | ||
| 035 | |a (PII)S0212-6567(23)00081-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Llor, Carl |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New paradigms on antibiotic recommendations for community-acquired infections in Spain |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.08.2023 | ||
| 500 | |a Date Revised 01.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a Over the last years, the susceptibility activity of the most common microorganisms causing community-acquired infections has significantly changed in Spain. Based on the susceptibility rates of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae collected from outpatients aged 15 or older with symptoms of respiratory or urinary tract infections in several Microbiology Departments in Catalonia in 2021, penicillin V should be first choice for most respiratory tract infections, amoxicillin and clavulanate for chronic obstructive pulmonary disease exacerbations and a single dose of fosfomycin or a short-course nitrofurantoin should remain first-line treatments for uncomplicated urinary tract infections. Updated information on antimicrobial resistance for general practitioners is crucial for achieving appropriate empirical management of the most common infections by promoting more rational antibiotic use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Administración antimicrobiana | |
| 650 | 4 | |a Agentes antibacterianos | |
| 650 | 4 | |a Anti-bacterial agents | |
| 650 | 4 | |a Antimicrobial stewardship | |
| 650 | 4 | |a Community-acquired infections | |
| 650 | 4 | |a Drug resistance, microbial | |
| 650 | 4 | |a Infecciones adquiridas en la comunidad | |
| 650 | 4 | |a Penicilina V | |
| 650 | 4 | |a Penicillin V | |
| 650 | 4 | |a Primary health care | |
| 650 | 4 | |a Primeros auxilios | |
| 650 | 4 | |a Resistencia a los medicamentos, microbiana | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Hoyos Mallecot, Yannick |e verfasserin |4 aut | |
| 700 | 1 | |a Moragas, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Troncoso-Mariño, Amelia |e verfasserin |4 aut | |
| 700 | 1 | |a Bjerrum, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Villmones, Heidi C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Atencion primaria |d 1991 |g 55(2023), 8 vom: 15. Aug., Seite 102648 |w (DE-627)NLM012612324 |x 1578-1275 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2023 |g number:8 |g day:15 |g month:08 |g pages:102648 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.aprim.2023.102648 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2023 |e 8 |b 15 |c 08 |h 102648 | ||